The USFDA has completed a successful inspection at the Piramal Pharma USA facility. The inspection was conducted to ensure that the facility meets all regulatory standards and requirements. This positive outcome reflects the company’s commitment to quality and compliance. Cookies are used on the website for analytics, advertising, and site improvement, and by continuing to use the site, users agree to their use. More information about cookies can be found in the Cookie Policy and Cookie Settings.
Source link
USFDA successfully concludes inspection at Piramal Pharma USA facility
